The modulation in the tumor immune landscapes as a result of HMGB1 inhibition in the context of radiation suggested that the radiosensitization effect observed in the combination group is likely immune mediated and highlights the impaction of HMGB1 immune functions in dictating the response of the tumor to radiation therapy. The gene discussed is HMGB1; the disease is neoplasm.